Spots Global Cancer Trial Database for Real World Data Collection Pediatric Neuroblastoma Treated With Lorlatinib
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Real World Data Collection Pediatric Neuroblastoma Treated With Lorlatinib
Official Title: REAL WORLD DATA COLLECTION AMONG PEDIATRIC NEUROBLASTOMA PATIENTS TREATED WITH LORLATINIB THROUGH EXPANDED ACCESS PROGRAM
Study ID: NCT04753658
Conditions
Interventions
Study Description
Brief Summary: The overall goal of this real-world data collection is to assess demographic, clinical characteristics and real-world effectiveness of pediatric neuroblastoma patients treated with lorlatinib through the expanded access program.
Detailed Description:
Keywords
Eligibility
Minimum Age: 0 Years
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States
Westmead Hospital, Westmead, New South Wales, Australia
ST0683AU - Chris O'Brien Lifehouse, Camperdown, New South Wales, 2050 Australia, , Australia
Seoul National University Bundang Hospital, Seongnam, , Korea, Republic of
Samsung medical Center, Seoul, , Korea, Republic of
Starship Blood and Cancer Centre, Auckland, , New Zealand
Instituto Portugues de Oncologia de Lisboa, Lisboa, , Portugal
Queen Silvia Children's Hospital, Gothenburg, , Sweden
HRH Crown Princess Victoria's Children and Youth Hospital, Linkoping, , Sweden
Karolinska Institutet, Stockholm, , Sweden
Norrland University Hospital, Umea, , Sweden
Contact Details
Name: Pfizer CT.gov Call Center
Affiliation: Pfizer
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
